Martina A. Sersch
Keine laufenden Positionen mehr
Profil
Martina A.
Sersch worked as an Executive Director at Amgen, Inc. from 2016 to 2018, and as a Senior Medical Director at Genentech, Inc. from 2011 to 2016.
She also served as the Chief Medical Officer at Mustang Bio, Inc. from 2018 to 2019, and at Gracell Biotechnologies, Inc. from 2020 to 2022.
Dr. Sersch obtained her undergraduate and doctorate degrees from Ruprecht-Karls-Universität Heidelberg.
Ehemalige bekannte Positionen von Martina A. Sersch
| Unternehmen | Position | Ende |
|---|---|---|
| GRACELL BIOTECHNOLOGIES INC. | Chief Tech/Sci/R&D Officer | 01.08.2022 |
| MUSTANG BIO, INC. | Chief Tech/Sci/R&D Officer | 01.09.2019 |
| AMGEN INC. | Director/Board Member | 01.09.2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01.01.2016 |
Ausbildung von Martina A. Sersch
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| MUSTANG BIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Gracell Biotechnologies, Inc.
 Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China. | Health Technology |
